| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 0 | ||||
| Sells | 3 | -33,316 | 100% | $11.28 | -$375,862 |
| Net | -3 | -33,316 | -100% | -$375,862 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Steven P. Coen | DNA | Class A Common Stock | Sale | -10.5% | $8,667 | $8.92 | -972 | 8,321 | 20 Jan 2026 | Direct |
| Steven P. Coen | DNA | Class A Common Stock | Options Exercise | 24.1% | 1,805 | 9,293 | 16 Jan 2026 | Direct | ||
| Steven P. Coen | DNA | Restricted Stock Units | Options Exercise | -100% | -1,805 | 0 | 16 Jan 2026 | Direct | ||
| Steven P. Coen | DNA | Class A Common Stock | Sale | -8.95% | $6,540 | $8.89 | -736 | 7,488 | 15 Dec 2025 | Direct |
| Steven P. Coen | DNA | Class A Common Stock | Options Exercise | 22% | 1,486 | 8,224 | 12 Dec 2025 | Direct | ||
| Steven P. Coen | DNA | Restricted Stock Units | Options Exercise | -26% | -1,486 | 4,223 | 12 Dec 2025 | Direct | ||
| Steven P. Coen | DNA | Class A Common Stock | Sale | -16.3% | $17,907 | $13.65 | -1,312 | 6,738 | 17 Oct 2025 | Direct |
| Steven P. Coen | DNA | Class A Common Stock | Options Exercise | 46.3% | 2,547 | 8,050 | 16 Oct 2025 | Direct | ||
| Steven P. Coen | DNA | Restricted Stock Units | Options Exercise | -70.6% | -2,547 | 1,062 | 16 Oct 2025 | Direct | ||
| Steven P. Coen | DNA | Class A Common Stock | Sale | -50.5% | $84,135 | $15.00 | -5,609 | 5,503 | 01 Oct 2025 | Direct |
| HENRY CHRISTIAN O. | DNA | Class A Common Stock | Sale | -29.2% | $110,600 | $11.06 | -10,000 | 24,310 | 09 Sep 2025 | Direct |
| HENRY CHRISTIAN O. | DNA | Class A Common Stock | Sale | -22.6% | $109,200 | $10.92 | -10,000 | 34,310 | 08 Sep 2025 | Direct |
| Steven P. Coen | DNA | Class A Common Stock | Sale | -2.71% | $3,843 | $12.40 | -310 | 11,112 | 22 Aug 2025 | Direct |
| Steven P. Coen | DNA | Class A Common Stock | Options Exercise | 6.96% | 743 | 11,422 | 21 Aug 2025 | Direct | ||
| Steven P. Coen | DNA | Restricted Stock Units | Options Exercise | -13.3% | -743 | 4,847 | 21 Aug 2025 | Direct | ||
| Steven P. Coen | DNA | Class A Common Stock | Sale | -9.22% | $10,669 | $9.84 | -1,084 | 10,679 | 17 Jul 2025 | Direct |
| Steven P. Coen | DNA | Class A Common Stock | Options Exercise | 27.6% | 2,547 | 11,763 | 16 Jul 2025 | Direct | ||
| Steven P. Coen | DNA | Restricted Stock Units | Options Exercise | -54.5% | -2,547 | 2,123 | 16 Jul 2025 | Direct | ||
| HARRY SLOAN | DNA | Stock Option | Award | 34,375 | 34,375 | 12 Jun 2025 | Direct | |||
| Shyam Sankar | DNA | Stock Option | Award | 34,375 | 34,375 | 12 Jun 2025 | Direct | |||
| Sri Kosuri | DNA | Stock Option | Award | 34,375 | 34,375 | 12 Jun 2025 | Direct | |||
| HENRY CHRISTIAN O. | DNA | Stock Option | Award | 34,375 | 34,375 | 12 Jun 2025 | Direct | |||
| Ross Fubini | DNA | Stock Option | Award | 34,375 | 34,375 | 12 Jun 2025 | Direct | |||
| MYRTLE S. POTTER | DNA | Class A Common Stock | Options Exercise | 10,822 | 10,822 | 11 Jun 2025 | Direct | |||
| MYRTLE S. POTTER | DNA | Restricted Stock Units | Options Exercise | -100% | -10,822 | 0 | 11 Jun 2025 | Direct | ||
| Kathy Hopinkah Hannan | DNA | Class A Common Stock | Options Exercise | 258.8% | 10,822 | 15,003 | 11 Jun 2025 | Direct | ||
| Kathy Hopinkah Hannan | DNA | Restricted Stock Units | Options Exercise | -100% | -10,822 | 0 | 11 Jun 2025 | Direct | ||
| HARRY SLOAN | DNA | Class A Common Stock | Options Exercise | 4.15% | 10,822 | 271,418 | 11 Jun 2025 | Direct | ||
| HARRY SLOAN | DNA | Restricted Stock Units | Options Exercise | -100% | -10,822 | 0 | 11 Jun 2025 | Direct | ||
| Shyam Sankar | DNA | Class A Common Stock | Options Exercise | 17.6% | 10,822 | 72,372 | 11 Jun 2025 | Direct | ||
| Shyam Sankar | DNA | Restricted Stock Units | Options Exercise | -100% | -10,822 | 0 | 11 Jun 2025 | Direct | ||
| Sri Kosuri | DNA | Class A Common Stock | Options Exercise | 24,067 | 24,067 | 11 Jun 2025 | Direct | |||
| Sri Kosuri | DNA | Restricted Stock Units | Options Exercise | -100% | -24,067 | 0 | 11 Jun 2025 | Direct | ||
| HENRY CHRISTIAN O. | DNA | Class A Common Stock | Options Exercise | 32.3% | 10,822 | 44,310 | 11 Jun 2025 | Direct | ||
| HENRY CHRISTIAN O. | DNA | Restricted Stock Units | Options Exercise | -100% | -10,822 | 0 | 11 Jun 2025 | Direct | ||
| Ross Fubini | DNA | Class A Common Stock | Options Exercise | 10,822 | 10,822 | 11 Jun 2025 | Direct | |||
| Ross Fubini | DNA | Restricted Stock Units | Options Exercise | -100% | -10,822 | 0 | 11 Jun 2025 | Direct | ||
| Steven P. Coen | DNA | Class A Common Stock | Sale | -3.62% | $2,624 | $7.58 | -346 | 9,216 | 21 May 2025 | Direct |
| Mark E. Dmytruk | DNA | Class A Common Stock | Sale | -1.5% | $5,355 | $7.58 | -706 | 46,226 | 21 May 2025 | Direct |
| Steven P. Coen | DNA | Class A Common Stock | Options Exercise | 8.42% | 743 | 9,562 | 20 May 2025 | Direct | ||
| Steven P. Coen | DNA | Restricted Stock Units | Options Exercise | -12.3% | -743 | 5,315 | 20 May 2025 | Direct | ||
| Mark E. Dmytruk | DNA | Class A Common Stock | Options Exercise | 3.25% | 1,479 | 46,932 | 20 May 2025 | Direct | ||
| Mark E. Dmytruk | DNA | Restricted Stock Units | Options Exercise | -29% | -1,479 | 3,614 | 20 May 2025 | Direct | ||
| Steven P. Coen | DNA | Class A Common Stock | Sale | -10.2% | $7,261 | $7.28 | -997 | 8,819 | 21 Apr 2025 | Direct |
| Mark E. Dmytruk | DNA | Class A Common Stock | Sale | -2.66% | $9,060 | $7.28 | -1,244 | 45,453 | 21 Apr 2025 | Direct |
| Steven P. Coen | DNA | Class A Common Stock | Options Exercise | 22.5% | 1,804 | 9,816 | 17 Apr 2025 | Direct | ||
| Steven P. Coen | DNA | Restricted Stock Units | Options Exercise | -36.2% | -1,804 | 3,184 | 17 Apr 2025 | Direct | ||
| Mark E. Dmytruk | DNA | Class A Common Stock | Options Exercise | 5.77% | 2,548 | 46,697 | 17 Apr 2025 | Direct | ||
| Mark E. Dmytruk | DNA | Class B Common Stock | Options Exercise | -0.14% | -8 | 5,906 | 17 Apr 2025 | Direct | ||
| Mark E. Dmytruk | DNA | Restricted Stock Units | Options Exercise | -44.4% | -2,540 | 3,184 | 17 Apr 2025 | Direct |